Published in Can Nurse on January 01, 1982
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50
The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci (1994) 3.53
THE RELATIVE PREVALENCE OF BACTERIA IN AN IMHOFF TANK. Am J Public Health (N Y) (1923) 3.40
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Neurology (2007) 3.17
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59
Dr Samuel Johnson's movement disorder. Br Med J (1979) 2.51
On the death of house officers. Ann Intern Med (1998) 2.34
Visual acuity and contrast sensitivity in multiple sclerosis--hidden visual loss: an auxiliary diagnostic test. Brain (1977) 2.01
Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci (1993) 1.87
Patterns of cannabis use among patients with multiple sclerosis. Neurology (2004) 1.78
The restless leg syndrome. Can Med Assoc J (1967) 1.62
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation. Mult Scler (2009) 1.52
A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry (2005) 1.50
Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr (1987) 1.48
A population-based study of multiple sclerosis in twins: update. Ann Neurol (1993) 1.46
Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain (1994) 1.42
Characteristics of patients found not to have multiple sclerosis. Can Med Assoc J (1984) 1.42
Relevance in undergraduate neurological teaching. Can J Neurol Sci (1977) 1.38
Treatment of essential tremor with propranolol. Can Med Assoc J (1972) 1.36
A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci (1992) 1.32
Auditory brainstem responses in postconcussion syndrome. Arch Neurol (1981) 1.26
Concepts in undergraduate neurological teaching. Clin Neurol Neurosurg (1977) 1.24
Congenital sensory neuropathy. Brain (1973) 1.21
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structures. J Am Chem Soc (2001) 1.14
Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci (1985) 1.07
Long-term therapy of essential tremor with propranolol. Can Med Assoc J (1976) 1.07
Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis. Brain (1981) 1.04
Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci (2003) 0.99
Presidential Address: XVIII Canadian Congress of Neurological Sciences. The neurologist as educator. Can J Neurol Sci (1983) 0.97
Effect of body temperature on visual evoked potential delay and visual perception in multiple sclerosis. J Neurol Neurosurg Psychiatry (1977) 0.96
Predicting sun spots using a layered perceptron neural network. IEEE Trans Neural Netw (1996) 0.96
Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates. Int J Technol Assess Health Care (2000) 0.95
Essential tremor. Can Med Assoc J (1981) 0.93
Spatial frequency discrimination in normal vision and in patients with multiple sclerosis. Brain (1982) 0.90
The scope of neurologic practice and care in England, Canada, and the United States. Is there a better way? Arch Neurol (1989) 0.90
Relationship between neurological and urological status in patients with multiple sclerosis. J Urol (1984) 0.90
Orientation-specific losses of contrast sensitivity in multiple sclerosis. Invest Ophthalmol Vis Sci (1980) 0.88
An unusual occurrence of multiple sclerosis in a small rural community. Can J Neurol Sci (1976) 0.87
Dichotic paradigms in multiple sclerosis. Ear Hear (1984) 0.87
Carbon monoxide poisoning from Sterno. Can Med Assoc J (1978) 0.87
Tourette's syndrome: a treatable tic. Can Med Assoc J (1978) 0.85
Drug therapy in multiple sclerosis: a study of Nova Scotia senior citizens. Clin Ther (1997) 0.83
Does a shift in the T-cell receptor repertoire precede the onset of MS? Neurology (1999) 0.82
Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires. Clin Exp Immunol (2003) 0.82
Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci (1998) 0.81
Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics (2001) 0.80
Carotidynia: a cause of neck and face pain. Can Med Assoc J (1979) 0.79
Psychosocial and neurological predictors of mental health in multiple sclerosis patients. J Clin Epidemiol (1996) 0.79
Division of the recurrent laryngeal nerve for idiopathic laryngeal spasm. J Otolaryngol (1987) 0.79
Patients with multiple sclerosis experience hearing loss specifically for shifts of tone frequency. Arch Neurol (1984) 0.78
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study. Mult Scler (2005) 0.78
Carbon monoxide in the modern society. Can Med Assoc J (1978) 0.77
Functional competence of community-dwelling persons with multiple sclerosis using the assessment of motor and process skills. Arch Phys Med Rehabil (1994) 0.77
Amyotrophic lateral sclerosis in Nova Scotia. Adv Exp Med Biol (1987) 0.77
Haloperiodl in the treatment of stuttering. Br J Psychiatry (1977) 0.77
Temporal arteritis. J Am Geriatr Soc (1977) 0.77
ALS incidence in Nova Scotia over a 20-year-period: a prospective study. Can J Neurol Sci (2007) 0.77
Effects of colchicine application to preganglionic axons on choline acetyltransferase activity and acetylcholine content and release in the superior cervical ganglion. J Neurochem (1996) 0.77
The effects of ABR stimulus repetition rate in multiple sclerosis. Ear Hear (1987) 0.77
John Stewart's case of sudden death: a reassessment. CMAJ (1985) 0.76
Risks of the neurologist's pin. N Engl J Med (1979) 0.76
Abnormal adaptation of visual contrast sensitivity in multiple sclerosis patients. Can J Neurol Sci (1981) 0.76
Rapid adaptation of translational vestibulo-ocular reflex: independence of retinal slip. Ann N Y Acad Sci (2002) 0.76
Doctor Samuel Johnson's abnormal movements. Adv Neurol (1982) 0.76
Degraded discrimination between speech-like sounds by patients with multiple sclerosis and Friedreich's ataxia. Brain (1984) 0.76
The neurology of Alice in Wonderland. Can J Neurol Sci (1982) 0.76
Musicogenic epilepsy. Can Med Assoc J (1984) 0.76
A model clinical neuroscience curriculum. Neurology (1987) 0.76
Narcolepsy. Can Med Assoc J (1974) 0.76
Rapid adaptation of translational vestibulo-ocular reflex: time course, consolidation, and specificity. Ann N Y Acad Sci (2002) 0.75
Nuchal infiltrations. Can Med Assoc J (1974) 0.75
What should a family physician know about neurology? Can Fam Physician (1990) 0.75
Motor neuron disease in Nova Scotia. Can Med Assoc J (1974) 0.75
Status epilepticus: a plan for management. Can Fam Physician (1983) 0.75
The management of chronic headaches. Can Fam Physician (1984) 0.75
How effective are disease-modifying drugs in delaying progression in relapsing-onset ms? Neurology (2008) 0.75
Tourette syndrome. Can Fam Physician (1982) 0.75
Delayed auditory tone perception in multiple sclerosis. Can J Neurol Sci (1983) 0.75
Target organ destruction enhances recovery of choline acetyltransferase activity in adult rat sympathetic ganglia after denervation. Exp Neurol (1987) 0.75
THE SUCCESSFUL TREATMENT OF MENINGO-ENCEPHALITIS, ASSOCIATED WITH CANINE DISTEMPER, WITH SULFANILAMIDE. Science (1939) 0.75
Herniation of L4, L5 intervertebral disc--direct examination of plaintiff's biomechanical engineer. Med Trial Tech Q (1981) 0.75
L-dopa therapy in Parkinson's disease. N S Med Bull (1972) 0.75
Hearing changes in multiple sclerosis. J Neurosurg Nurs (1983) 0.75
Conceptual reasoning as a mediator of verbal recall in patients with multiple sclerosis. J Clin Exp Neuropsychol (1996) 0.75
Letter: Multiple sclerosis and viral infections. Lancet (1976) 0.75
Narcolepsy. Can Med Assoc J (1974) 0.75
Neurology and the community. Can J Neurol Sci (1996) 0.75
The Feminine Mystique. Can Med Assoc J (1964) 0.75
Multiple sclerosis in a rural community. Neurology (1976) 0.75
Exodus of physicians. Can Med Assoc J (1984) 0.75
No increase in multiple sclerosis among veterinarians. N Engl J Med (1981) 0.75